alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › intranasal

intranasal

3 studies tagged intranasal, dated 2013-05-13 to 2024-08-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease 2024-08-01
  2. Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development 2022-11-16
  3. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration 2013-05-13

Studies

3 studies carry this tag.

Date range

2013 to 2024

Top journals

  • Alzheimer's research & therapy 1
  • Cells 1
  • International journal of pharmaceutics 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Alzheimer's research & therapy 2024-08-01 Drug development

    Targeting brain insulin resistance (BIR) has become an attractive alternative to traditional therapeutic treatments for Alzheimer's disease (AD).

  2. Intranasal Peptide Therapeutics: A Promising Avenue for Overcoming the Challenges of Traditional CNS Drug Development

    ✓ Peer-reviewed alzhub usefulness score 43 out of 100. Cells 2022-11-16 Drug development

    The central nervous system (CNS) has, among all organ systems in the human body, the highest failure rate of traditional small-molecule drug development, ranging from 80-100% depending on the area of disease research.

  3. Enhanced brain distribution and pharmacodynamics of rivastigmine by liposomes following intranasal administration

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. International journal of pharmaceutics 2013-05-13 Treatments

    Alzheimer's disease (AD) is a common progressive neurodegenerative disorder associated with cholinergic neurons degeneration.

All topic tags with their study counts